BioVaxys Technology ( ($TSE:BIOV) ) just unveiled an announcement. BioVaxys’ 2025 corporate review highlights the integration of the DPX platform ...

Novavax ( (NVAX)) has released its Q3 earnings. Here is a breakdown of the information Novavax presented to its investors. Novavax, Inc., based in Gaithersburg, Maryland, is a global biotechnology ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

A recent study published in Nature Immunology showed that germline-targeting epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human immunodeficiency ...

Although development of a jab for the H5N1 strain of avian flu is well under way, other strains are receiving less attention — and political obstacles to research could hamper progress.

Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a new approach to the development of COVID-19 vaccines and monoclonal antibodies (mAbs) to restore public trust in health ...

Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at pharmaceutical giants Eli Lilly and Pfizer that anti-vaccine activist Robert F.

Natal (UKZN) is among key institutions under investigation by the Special Investigating Unit (SIU) over alleged ...

Focused on next-generation vaccines for bacterial diseases, this biotech just reported a notable insider sale amid a ...

The search for vaccines to fight poliomyelitis started in the 1920s, but it wasn't until the 1950s that the search bore fruit with the introduction of two vaccines. The first was the Salk inactivated ...